Patents Assigned to IMGT CO, LTD.
  • Publication number: 20240122853
    Abstract: Provided is a composition comprising sonosensitive liposomes for penetrating the blood-brain barrier, wherein the sonosensitive liposomes have excellent drug loading efficiency and ultrasound-induced drug release effect and can effectively penetrating the blood-brain barrier during ultrasound stimulation, and the sonosensitive liposomes can circulate in the body for a long time, and thus have better blood-brain barrier penetration efficiency, a high affinity for brain tumor cells, and excellent delivery effect to tumor sites and can be used as a drug delivery system for delivering brain disease therapeutic agents and the like to the brain.
    Type: Application
    Filed: February 7, 2022
    Publication date: April 18, 2024
    Applicant: IMGT CO, LTD.
    Inventors: Hyungwon MOON, Yoonseok KIM, Eun Ah JUNG, Hyun Ryoung KIM
  • Patent number: 11753489
    Abstract: The present invention relates to novel nanoparticles using an anionic polymer, a preparation method thereof, a composition, and the like, and the present invention is used for a method of necrosing cancer cells by blocking major blood vessels that supply nutrients to cancer cells to induce an embolic effect, and thus may be used for the treatment of patients with cancer.
    Type: Grant
    Filed: February 9, 2021
    Date of Patent: September 12, 2023
    Assignee: IMGT CO, LTD.
    Inventors: Seung Ki Kim, Hyun Ryoung Kim, Eun Ah Jung, Woo Ram Cho
  • Patent number: 11617723
    Abstract: The present invention aims to dramatically increase the effect of hepatic arterial chemoembolization by developing human serum albumin-based nanoparticles, which are bioproteins that effectively carry Adriamycin in place of Adriamycin, an anticancer agent used in hepatic arterial chemoembolization. The human serum albumin nanoparticles carrying the Adriamycin not only intensively infiltrate the drug effectively into the cells but also have a synergistic effect that can induce a long-term therapeutic effect by utilizing the effect of continuous drug release from the particles.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: April 4, 2023
    Assignees: SOGANG UNIVERSITY RESEARCH FOUNDATION, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, IMGT CO, LTD.
    Inventors: Hyun Cheol Kim, Jin Wook Chung, Eun Ah Jung
  • Publication number: 20220305139
    Abstract: Provided is an immune microbubble complex, and a use thereof. An immune-microbubble complex (IMC) according to the presently claimed subject matter includes microbubbles to which an antibody is conjugated, in which the microbubbles have excellent stability and excellent antibody binding strength, and it was confirmed that, when the immune-microbubble complex is treated with high-intensity focused ultrasound (HIFU), an anti-tumor effect is significantly increased and an immune-enhancing effect is exhibited. Therefore, the immune-microbubble complex according to the presently claimed subject matter is expected to increase the efficiency of delivering the conjugated antibody and be used in both diagnosis and treatment of cancer, and exhibit various functions in the field of immunotherapy, including a contrast effect, half-life improvement, improved drug delivery, a lymphocyte concentration effect, cancer immunotherapy and induction of immunotherapy using ultrasound.
    Type: Application
    Filed: September 1, 2020
    Publication date: September 29, 2022
    Applicant: IMGT CO, LTD.
    Inventors: Daehyun KIM, Hyun Ryoung KIM, Eun Ah JUNG
  • Patent number: 10912848
    Abstract: The present invention provides a dual-purpose photoacoustic tomography (PAT)/ultrasound contrast agent comprising: (a) a micro-bubble containing gas and porphyrin therein; and (b) nanoparticles bound on a surface of the micro-bubble and containing a drug. The contrast agent of the present invention can be used in both the ultrasound diagnosis and the photoacoustic image diagnosis, and can significantly increase the accuracy of photoacoustic images.
    Type: Grant
    Filed: October 13, 2014
    Date of Patent: February 9, 2021
    Assignee: IMGT CO, LTD.
    Inventors: Hyun Cheol Kim, Hyung Won Moon, Jin Ho Chang
  • Publication number: 20170080114
    Abstract: The present invention provides a dual-purpose photoacoustic tomography (PAT)/ultrasound contrast agent comprising: (a) a micro-bubble containing gas and porphyrin therein; and (b) nanoparticles bound on a surface of the micro-bubble and containing a drug. The contrast agent of the present invention can be used in both the ultrasound diagnosis and the photoacoustic image diagnosis, and can significantly increase the accuracy of photoacoustic images.
    Type: Application
    Filed: October 13, 2014
    Publication date: March 23, 2017
    Applicant: IMGT CO, LTD.
    Inventors: HYUN CHEOL KIM, HYUNG WON MOON, JIN HO CHANG